Condition: Colon Cancer · Sponsor: Russian Society of Colorectal Surgeons
The efficiency of the D3 lymph node dissection is still controversial for left colon cancer patients. This study will try find difference in 5-year overall survival between D2 and D3 lymph node dissection. Investigation of the functional and short-term outcomes will clarify safety of the D3 lymph node dissection.
This description comes directly from the study's public registry record.
Vladimir Balaban, Ph.D · +79889478358 · balaban@kkmx.ru
Inna Tulina, Ph.D · +79264086672 · tulina@kkmx.ru
Always discuss trial participation with your own doctor first.
| Clinic of coloproctology and minimally invasive surgery | Moscow, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04364373